Our Parkinson's Place: Amarantus issues Chinese patent covering use of MANF for the treatment of Parkinson's

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

Friday, January 29, 2016

Amarantus issues Chinese patent covering use of MANF for the treatment of Parkinson's

29 Jan 2016

The patent issuance will provide intellectual property protection in China for protein therapy, gene therapy and cell therapy applications of MANF.

Amarantus develops treatments and diagnostics for diseases in the areas of regenerative medicine neurology, and orphan diseases.

Amarantus BioScience Holdings (OTCMKTS:AMBS), a biotechnology company, issued a Chinese patent entitled "Neurodegenerative Disorders" covering the use of MANF for the treatment of Parkinson's disease.

The claims issued extend patent coverage for MANF protein therapy, gene therapy and cell therapy applications into 2029, the San Francisco, California-based company said in a statement on Thursday.

"The Chinese market represents a potential significant market opportunity for Amarantus," CEO Gerald Commissiong said in the statement.

The company said on Friday that it will look to partner the development of MANF with a group in China capable of bringing that technology to market in that region.

This patent adds to Amarantus' international intellectual property portfolio covering compositions of matter, methods of use and formulations for MANF.

Shares fell 8.6% to $0.323 at 12:21 p.m. in New York, reversing an earlier gain

http://www.proactiveinvestors.com/companies/news/121962/amarantus-issues-chinese-patent-covering-use-of-manf-for-the-treatment-of-parkinson-s-121962.html?